SODIUM BICARBONATE, INJECTION

SODIUM BICARBONATE, INJECTION was reported 23575 times

SODIUM BICARBONATE, INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 27 0.9000
1 FOETAL BIOPHYSICAL PROFILE SCORE ABNORMAL 19 0.6129
2 CENTRAL NERVOUS SYSTEM MASS 44 0.4632
3 VAGINAL FLATULENCE 132 0.4356
4 WALL MOTION SCORE INDEX ABNORMAL 45 0.4091
5 AIRWAY REMODELLING 44 0.3548
6 VENA CAVA INJURY 28 0.3043
7 PERINEAL CYST 22 0.3014
8 ANTACID THERAPY 38 0.2923
9 SLEEP DISORDER THERAPY 54 0.2727
10 APPENDICOLITH 77 0.1990
11 RENAL CYST HAEMORRHAGE 40 0.1770
12 SENSITISATION 134 0.1765
13 EJECTION FRACTION 101 0.1738
14 ANALGESIC THERAPY 52 0.1620
15 ATOPY 44 0.1583
16 DRUG THERAPY 46 0.1357
17 ANTICOAGULANT THERAPY 37 0.1303
18 IRON BINDING CAPACITY TOTAL DECREASED 26 0.1176
19 CONGENITAL HIATUS HERNIA 22 0.0965
20 ABDOMINAL WALL HAEMORRHAGE 24 0.0920
21 MALIGNANT MELANOMA STAGE 0 19 0.0909
22 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 27 0.0891
23 POLYCYSTIC OVARIES 131 0.0844
24 FEMALE GENITAL TRACT FISTULA 142 0.0831
25 DELAYED GRAFT FUNCTION 58 0.0816
26 BACTEROIDES INFECTION 21 0.0805
27 VASCULAR COMPRESSION 25 0.0791
28 HYPERPARATHYROIDISM SECONDARY 192 0.0766
29 CARBUNCLE 21 0.0742
30 EJECTION FRACTION ABNORMAL 74 0.0604
31 EOSINOPHILIC MYOCARDITIS 44 0.0603
32 NEPHROGENIC ANAEMIA 274 0.0591
33 CARDIAC SEPTAL DEFECT 42 0.0584
34 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 61 0.0574
35 RADICULOPATHY 145 0.0550
36 HYPERPHOSPHATAEMIA 118 0.0548
37 CHRONIC SINUSITIS 201 0.0535
38 BLOOD PHOSPHORUS INCREASED 133 0.0487
39 METABOLIC ALKALOSIS 77 0.0480
40 MICROANGIOPATHY 45 0.0479
41 PROCTITIS 134 0.0478
42 ALKALOSIS 18 0.0471
43 DRUG CLEARANCE DECREASED 60 0.0459
44 ANION GAP 27 0.0426
45 RENAL ARTERY STENOSIS 54 0.0392
46 OBSTRUCTIVE SLEEP APNOEA SYNDROME 57 0.0391
47 INCISION SITE PAIN 45 0.0383
48 RED BLOOD CELLS URINE POSITIVE 37 0.0383
49 CAROTID ARTERIOSCLEROSIS 39 0.0378
50 NEPHRECTOMY 54 0.0363
51 INTERVERTEBRAL DISC SPACE NARROWING 29 0.0360
52 BLOOD ALKALINE PHOSPHATASE DECREASED 32 0.0337
53 AORTIC DILATATION 37 0.0333
54 RHINITIS ALLERGIC 145 0.0325
55 WRIST DEFORMITY 20 0.0325
56 CRYSTAL NEPHROPATHY 18 0.0304
57 MONOCLONAL IMMUNOGLOBULIN PRESENT 23 0.0303
58 RECTAL PROLAPSE 36 0.0298
59 END STAGE RENAL DISEASE 530 0.0290
60 HYPERCHLORAEMIA 18 0.0281
61 CARBON DIOXIDE DECREASED 32 0.0278
62 SUPERFICIAL VEIN THROMBOSIS 23 0.0273
63 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 25 0.0270
64 COMPLICATIONS OF TRANSPLANTED KIDNEY 61 0.0269
65 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 129 0.0255
66 TOTAL LUNG CAPACITY DECREASED 40 0.0250
67 RESPIRATORY SYMPTOM 66 0.0232
68 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 118 0.0230
69 MACULAR DEGENERATION 274 0.0229
70 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 45 0.0220
71 BLOOD CHLORIDE INCREASED 38 0.0220
72 HYPERURICAEMIA 88 0.0214
73 RENAL TUBULAR ACIDOSIS 46 0.0211
74 MEAN CELL VOLUME INCREASED 54 0.0210
75 EOSINOPHIL COUNT DECREASED 49 0.0206
76 BLOOD IMMUNOGLOBULIN E INCREASED 48 0.0198
77 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 21 0.0198
78 FOETAL HEART RATE ABNORMAL 18 0.0194
79 AORTIC STENOSIS 67 0.0192
80 RENAL ATROPHY 24 0.0192
81 BLOOD URIC ACID INCREASED 111 0.0192
82 RENAL TRANSPLANT 68 0.0188
83 LUNG OPACITY 49 0.0186
84 NEPHROGENIC SYSTEMIC FIBROSIS 56 0.0185
85 KIDNEY TRANSPLANT REJECTION 88 0.0183
86 AORTIC ARTERIOSCLEROSIS 47 0.0182
87 HYPOPROTEINAEMIA 34 0.0179
88 IRON DEFICIENCY 79 0.0175
89 HYPOPHOSPHATAEMIA 128 0.0173
90 METABOLIC ACIDOSIS 550 0.0172
91 VENTRICULAR HYPOKINESIA 55 0.0171
92 HYPOCHLORAEMIA 20 0.0171
93 ACUTE LUNG INJURY 20 0.0169
94 VENTRICULAR FIBRILLATION 187 0.0168
95 EOSINOPHILIC PNEUMONIA 52 0.0165
96 HYPERNATRAEMIA 82 0.0164
97 BLOOD BICARBONATE DECREASED 31 0.0164
98 URETERIC OBSTRUCTION 22 0.0161
99 FANCONI SYNDROME ACQUIRED 28 0.0159
100 ACTINIC KERATOSIS 41 0.0158
101 HYPOALBUMINAEMIA 121 0.0155
102 BICYTOPENIA 30 0.0153
103 HYPOTHALAMO-PITUITARY DISORDER 22 0.0151
104 LEFT VENTRICULAR HYPERTROPHY 64 0.0149
105 BLOOD POTASSIUM INCREASED 241 0.0148
106 HEPATOSPLENOMEGALY 38 0.0148
107 CALCIPHYLAXIS 27 0.0147
108 ACIDOSIS 112 0.0146
109 REBOUND ACID HYPERSECRETION 44 0.0145
110 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 23 0.0143
111 NEPHROPATHY 133 0.0142
112 CARDIOGENIC SHOCK 204 0.0142
113 PROTEIN URINE PRESENT 70 0.0140
114 BLOOD TEST ABNORMAL 197 0.0140
115 KIDNEY FIBROSIS 24 0.0138
116 ANION GAP INCREASED 18 0.0135
117 ORAL CANDIDIASIS 175 0.0133
118 HYPERVOLAEMIA 65 0.0131
119 ISCHAEMIC HEPATITIS 18 0.0131
120 HYPERPARATHYROIDISM 27 0.0131
121 VAGINAL DISCHARGE 132 0.0130
122 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 43 0.0130
123 RENAL FAILURE CHRONIC 100 0.0130
124 METHAEMOGLOBINAEMIA 30 0.0129
125 LYMPHOCYTE COUNT DECREASED 226 0.0128
126 BLOOD UREA INCREASED 214 0.0128
127 PARAESTHESIA ORAL 180 0.0125
128 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 32 0.0124
129 BLOOD PH DECREASED 21 0.0123
130 ACCIDENT AT WORK 27 0.0122
131 BENIGN PROSTATIC HYPERPLASIA 63 0.0122
132 HYPERKALAEMIA 422 0.0120
133 PULSELESS ELECTRICAL ACTIVITY 50 0.0120
134 PUPIL FIXED 20 0.0115
135 AZOTAEMIA 46 0.0115
136 CHRONIC KIDNEY DISEASE 875 0.0115
137 RENAL TUBULAR NECROSIS 112 0.0114
138 SPINAL STENOSIS 47 0.0114
139 FIBROSIS 35 0.0114
140 TUMOUR LYSIS SYNDROME 100 0.0114
141 MULTI-ORGAN FAILURE 196 0.0113
142 ACUTE KIDNEY INJURY 1735 0.0113
143 TOXIC EPIDERMAL NECROLYSIS 171 0.0112
144 DIVERTICULUM INTESTINAL 49 0.0112
145 SKIN INDURATION 23 0.0111
146 CARDIOVASCULAR INSUFFICIENCY 18 0.0110
147 RENAL INJURY 325 0.0109
148 PNEUMOPERITONEUM 20 0.0108
149 DIASTOLIC DYSFUNCTION 33 0.0107
150 BLOOD ALBUMIN DECREASED 84 0.0106
151 AORTIC VALVE INCOMPETENCE 45 0.0106
152 RENAL FAILURE 1400 0.0105
153 DIALYSIS 148 0.0104
154 CARPAL TUNNEL SYNDROME 145 0.0103
155 NEUTROPHIL COUNT INCREASED 105 0.0102
156 CLONUS 28 0.0102
157 BLOOD CREATININE INCREASED 665 0.0102
158 APLASIA PURE RED CELL 35 0.0102
159 BLOOD IMMUNOGLOBULIN G DECREASED 25 0.0101
160 EOSINOPHIL COUNT INCREASED 84 0.0101
161 ANHEDONIA 262 0.0100
162 ESSENTIAL HYPERTENSION 18 0.0098
163 APPENDICITIS 91 0.0097
164 HYPOVOLAEMIA 57 0.0097
165 ATRIOVENTRICULAR BLOCK FIRST DEGREE 42 0.0097
166 FEBRILE BONE MARROW APLASIA 41 0.0096
167 CEREBRAL HAEMATOMA 32 0.0095
168 MYASTHENIA GRAVIS 76 0.0094
169 HYPOCALCAEMIA 177 0.0093
170 HYDRONEPHROSIS 70 0.0093
171 NASAL POLYPS 46 0.0093
172 FINGER DEFORMITY 45 0.0093
173 DISTRIBUTIVE SHOCK 21 0.0093
174 TUBULOINTERSTITIAL NEPHRITIS 173 0.0092
175 HAEMODYNAMIC INSTABILITY 70 0.0092
176 FULL BLOOD COUNT ABNORMAL 97 0.0092
177 TROPONIN INCREASED 69 0.0091
178 VASCULAR DEVICE INFECTION 41 0.0090
179 HYPOKALAEMIA 417 0.0090
180 RENAL CYST 71 0.0089
181 HYPERLIPIDAEMIA 106 0.0089
182 LEFT VENTRICULAR FAILURE 30 0.0087
183 ATRIOVENTRICULAR BLOCK 67 0.0087
184 DYSLIPIDAEMIA 44 0.0087
185 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 19 0.0086
186 FEAR 232 0.0086
187 RENAL IMPAIRMENT 723 0.0086
188 BLOOD PARATHYROID HORMONE INCREASED 25 0.0086
189 HYPERLACTACIDAEMIA 23 0.0086
190 BILIRUBIN CONJUGATED INCREASED 20 0.0086
191 GLOMERULAR FILTRATION RATE DECREASED 104 0.0085
192 MULTIPLE ORGAN DYSFUNCTION SYNDROME 239 0.0084
193 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 143 0.0084
194 RENAL DISORDER 389 0.0083
195 METABOLIC ENCEPHALOPATHY 25 0.0083
196 CYTOMEGALOVIRUS COLITIS 19 0.0083
197 VENTRICULAR ARRHYTHMIA 30 0.0082
198 PROCEDURAL HAEMORRHAGE 32 0.0082
199 SLEEP APNOEA SYNDROME 155 0.0081
200 VENTRICULAR TACHYCARDIA 134 0.0081
201 BLOOD CALCIUM DECREASED 91 0.0081
202 INTESTINAL ISCHAEMIA 44 0.0080
203 VARICELLA 19 0.0079
204 SQUAMOUS CELL CARCINOMA OF SKIN 48 0.0079
205 RESPIRATORY ACIDOSIS 31 0.0079
206 PYELONEPHRITIS 68 0.0078
207 STAPHYLOCOCCAL BACTERAEMIA 34 0.0078
208 URINE OUTPUT DECREASED 68 0.0078
209 BRAIN DEATH 24 0.0078
210 ELECTROLYTE IMBALANCE 90 0.0077
211 TACHYARRHYTHMIA 19 0.0076
212 PLEURITIC PAIN 21 0.0076
213 PNEUMONIA FUNGAL 30 0.0076
214 COMA SCALE ABNORMAL 22 0.0076
215 BLOOD LACTIC ACID INCREASED 40 0.0076
216 SKIN HYPERTROPHY 21 0.0075
217 BLOOD CREATINE INCREASED 33 0.0074
218 RENAL FAILURE ACUTE 315 0.0074
219 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 28 0.0073
220 EUGLYCAEMIC DIABETIC KETOACIDOSIS 30 0.0073
221 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 19 0.0072
222 HYPOTHYROIDISM 231 0.0072
223 CARDIAC FAILURE ACUTE 48 0.0072
224 GOUT 129 0.0072
225 BLOOD CALCIUM INCREASED 63 0.0072
226 CYTOMEGALOVIRUS INFECTION 119 0.0072
227 BLOOD POTASSIUM ABNORMAL 19 0.0071
228 SINUS TACHYCARDIA 101 0.0071
229 BRAIN HERNIATION 21 0.0070
230 CYTOMEGALOVIRUS VIRAEMIA 31 0.0070
231 HYPOMAGNESAEMIA 97 0.0070
232 BLOOD CREATININE ABNORMAL 24 0.0069
233 OLIGURIA 43 0.0069
234 BREATH SOUNDS ABNORMAL 34 0.0069
235 LUNG CONSOLIDATION 19 0.0068
236 TRANSPLANT REJECTION 54 0.0067
237 FEBRILE NEUTROPENIA 447 0.0067
238 IMMUNE THROMBOCYTOPENIC PURPURA 19 0.0067
239 CYTOKINE RELEASE SYNDROME 134 0.0067
240 ASCITES 196 0.0067
241 HYPERCAPNIA 20 0.0066
242 HIGH DENSITY LIPOPROTEIN DECREASED 22 0.0066
243 BLOOD MAGNESIUM DECREASED 57 0.0066
244 KLEBSIELLA INFECTION 33 0.0065
245 BK VIRUS INFECTION 22 0.0065
246 PROTEINURIA 124 0.0065
247 SPINAL OSTEOARTHRITIS 57 0.0065
248 BACTERAEMIA 77 0.0065
249 RHINOVIRUS INFECTION 25 0.0064
250 PERIPHERAL ISCHAEMIA 26 0.0064
251 FIBROMYALGIA 154 0.0063
252 HYPERREFLEXIA 22 0.0063
253 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 41 0.0063
254 PROCEDURAL PAIN 175 0.0063
255 CAROTID ARTERY STENOSIS 22 0.0063
256 LYMPHOPENIA 89 0.0063
257 HEPARIN-INDUCED THROMBOCYTOPENIA 31 0.0063
258 SERUM FERRITIN INCREASED 33 0.0063
259 SEPTIC SHOCK 272 0.0062
260 ACUTE RESPIRATORY DISTRESS SYNDROME 110 0.0062
261 FREQUENT BOWEL MOVEMENTS 168 0.0062
262 ENTEROCOCCAL INFECTION 30 0.0062
263 COAGULOPATHY 103 0.0062
264 ASPIRATION 67 0.0061
265 PROTEIN TOTAL DECREASED 23 0.0061
266 NECROSIS 34 0.0061
267 CATHETER SITE INFECTION 23 0.0061
268 LEUKOCYTOSIS 110 0.0061
269 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
270 LACTIC ACIDOSIS 195 0.0060
271 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
272 RECTAL HAEMORRHAGE 258 0.0060
273 SKIN NECROSIS 31 0.0060
274 ANAEMIA 1137 0.0060
275 ARTERIOSCLEROSIS 56 0.0059
276 COLITIS 225 0.0059
277 FIBRIN D DIMER INCREASED 21 0.0059
278 PNEUMOCYSTIS JIROVECII PNEUMONIA 59 0.0059
279 OBSTRUCTIVE AIRWAYS DISORDER 65 0.0058
280 CIRCULATORY COLLAPSE 99 0.0058
281 LARGE INTESTINE POLYP 40 0.0058
282 BLOOD PHOSPHORUS DECREASED 21 0.0057
283 NEPHROPATHY TOXIC 64 0.0057
284 ONYCHOMYCOSIS 25 0.0057
285 BACTERIAL INFECTION 106 0.0057
286 PULSE ABSENT 27 0.0057
287 UROSEPSIS 52 0.0056
288 SUPRAVENTRICULAR EXTRASYSTOLES 19 0.0056
289 CLOSTRIDIAL INFECTION 19 0.0056
290 CUSHINGOID 18 0.0056
291 SWELLING OF EYELID 35 0.0056
292 CLOSTRIDIUM DIFFICILE COLITIS 59 0.0056
293 PARTIAL SEIZURES 29 0.0055
294 BACTERIAL SEPSIS 18 0.0055
295 SHOCK 127 0.0055
296 PROTHROMBIN TIME PROLONGED 33 0.0055
297 ENCEPHALOPATHY 134 0.0055
298 HYPERCALCAEMIA 67 0.0054
299 NEUTROPHIL COUNT DECREASED 220 0.0054
300 VITAMIN D DECREASED 46 0.0054
301 ACUTE PULMONARY OEDEMA 30 0.0053
302 HYPERTRANSAMINASAEMIA 37 0.0053
303 ILEUS 66 0.0053
304 PERIPHERAL SENSORY NEUROPATHY 31 0.0053
305 RHABDOMYOLYSIS 221 0.0053
306 HYPERTRIGLYCERIDAEMIA 31 0.0053
307 DRUG LEVEL INCREASED 87 0.0053
308 ACUTE RESPIRATORY FAILURE 101 0.0052
309 RESPIRATORY DEPRESSION 64 0.0052
310 FAILURE TO THRIVE 27 0.0052
311 FLUID INTAKE REDUCED 26 0.0052
312 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 89 0.0052
313 CARDIAC ARREST 427 0.0052
314 DECUBITUS ULCER 42 0.0051
315 HAEMODIALYSIS 43 0.0051
316 SEPSIS 571 0.0051
317 HYPONATRAEMIA 288 0.0051
318 VENOUS THROMBOSIS 20 0.0051
319 PLEURAL EFFUSION 310 0.0051
320 BONE MARROW FAILURE 103 0.0051
321 BRONCHIECTASIS 34 0.0050
322 HYPOXIA 177 0.0050
323 GENERALISED TONIC-CLONIC SEIZURE 83 0.0050
324 TACHYPNOEA 68 0.0050
325 CREATININE RENAL CLEARANCE DECREASED 20 0.0050
326 MENTAL STATUS CHANGES 138 0.0050
327 TOXIC ENCEPHALOPATHY 25 0.0049
328 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
329 RESPIRATORY FAILURE 358 0.0049
330 MUCOSAL INFLAMMATION 128 0.0049
331 HAEMOGLOBIN DECREASED 501 0.0049
332 CARDIOMEGALY 60 0.0049
333 STATUS EPILEPTICUS 55 0.0049
334 PERITONITIS BACTERIAL 49 0.0049
335 BRADYCARDIA 257 0.0048
336 MONOPLEGIA 21 0.0048
337 RALES 28 0.0048
338 FLUID OVERLOAD 70 0.0048
339 PULMONARY HYPERTENSION 100 0.0048
340 LACERATION 45 0.0048
341 C-REACTIVE PROTEIN INCREASED 174 0.0048
342 MALNUTRITION 53 0.0047
343 UNRESPONSIVE TO STIMULI 122 0.0047
344 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 336 0.0047
345 TORSADE DE POINTES 37 0.0047
346 OBESITY 75 0.0047
347 DEVICE RELATED INFECTION 72 0.0047
348 TRANSFUSION 49 0.0047
349 PSEUDOMONAS INFECTION 40 0.0047
350 PERIPHERAL VASCULAR DISORDER 24 0.0047
351 FAECES HARD 18 0.0046
352 RED BLOOD CELL COUNT DECREASED 132 0.0046
353 BLOOD LACTATE DEHYDROGENASE INCREASED 73 0.0046
354 NODULE 60 0.0046
355 DRUG LEVEL ABOVE THERAPEUTIC 21 0.0046
356 HAEMATURIA 157 0.0046
357 ISCHAEMIA 21 0.0046
358 DEPRESSED LEVEL OF CONSCIOUSNESS 179 0.0045
359 ENDOCARDITIS 23 0.0045
360 ATRIOVENTRICULAR BLOCK COMPLETE 30 0.0045
361 BLOOD TRIGLYCERIDES INCREASED 79 0.0045
362 POOR PERIPHERAL CIRCULATION 19 0.0045
363 ATELECTASIS 43 0.0044
364 GRAFT VERSUS HOST DISEASE 32 0.0044
365 ECONOMIC PROBLEM 67 0.0044
366 THROMBOTIC MICROANGIOPATHY 43 0.0044
367 PNEUMONIA ASPIRATION 110 0.0044
368 ULCER 70 0.0044
369 PULMONARY OEDEMA 197 0.0044
370 NEUROTOXICITY 77 0.0044
371 ENTERITIS 28 0.0044
372 HAEMATOCRIT DECREASED 86 0.0043
373 ELECTROCARDIOGRAM ABNORMAL 34 0.0043
374 DUODENAL ULCER PERFORATION 32 0.0043
375 ANURIA 37 0.0043
376 WRONG PRODUCT ADMINISTERED 29 0.0043
377 HYPOTENSION 861 0.0043
378 OVERWEIGHT 23 0.0043
379 CARDIOTOXICITY 38 0.0043
380 PANCYTOPENIA 238 0.0043
381 ELECTROCARDIOGRAM QT PROLONGED 153 0.0042
382 SKIN TIGHTNESS 20 0.0042
383 HEPATIC STEATOSIS 79 0.0042
384 CARDIAC FAILURE CHRONIC 18 0.0042
385 MYOCARDIAL ISCHAEMIA 48 0.0042
386 SUSPECTED OFF LABEL USE 19 0.0042
387 HAEMORRHOIDS 82 0.0042
388 BRAIN INJURY 42 0.0042
389 ENTEROCOLITIS 24 0.0042
390 HEPATIC CYTOLYSIS 53 0.0042
391 POLYURIA 34 0.0041
392 HYPERBILIRUBINAEMIA 43 0.0041
393 GANGRENE 25 0.0041
394 HYPERCHOLESTEROLAEMIA 40 0.0041
395 BUNDLE BRANCH BLOCK RIGHT 19 0.0041
396 GENERALISED OEDEMA 51 0.0041
397 HYPERGLYCAEMIA 150 0.0041
398 HAEMATOCHEZIA 226 0.0041
399 CYTOPENIA 50 0.0041
400 DIVERTICULUM 29 0.0041
401 WHITE BLOOD CELL COUNT INCREASED 156 0.0041
402 C-REACTIVE PROTEIN ABNORMAL 26 0.0040
403 STAPHYLOCOCCAL SEPSIS 20 0.0040
404 MALABSORPTION 21 0.0040
405 CLOSTRIDIUM DIFFICILE INFECTION 87 0.0040
406 INJURY 280 0.0040
407 GASTROENTERITIS 58 0.0040
408 GASTROOESOPHAGEAL REFLUX DISEASE 319 0.0040
409 ORTHOSTATIC HYPOTENSION 69 0.0040
410 LUNG INFILTRATION 35 0.0040
411 BRAIN OEDEMA 50 0.0040
412 JOINT RANGE OF MOTION DECREASED 53 0.0039
413 SHOCK HAEMORRHAGIC 32 0.0039
414 BLOOD POTASSIUM DECREASED 118 0.0039
415 TRICUSPID VALVE INCOMPETENCE 31 0.0039
416 LOW BIRTH WEIGHT BABY 31 0.0039
417 BLOOD BILIRUBIN INCREASED 105 0.0039
418 HAEMOLYSIS 30 0.0039
419 HEPATIC FAILURE 117 0.0039
420 NEURALGIA 94 0.0039
421 THROMBOCYTOPENIA 432 0.0039
422 HYPOTHERMIA 39 0.0038
423 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 185 0.0038
424 PRESYNCOPE 93 0.0038
425 ASPARTATE AMINOTRANSFERASE INCREASED 203 0.0038
426 AGRANULOCYTOSIS 71 0.0038
427 INFUSION RELATED REACTION 252 0.0038
428 HYPOVOLAEMIC SHOCK 18 0.0038
429 PLATELET COUNT DECREASED 400 0.0037
430 OESOPHAGITIS 41 0.0037
431 UPPER GASTROINTESTINAL HAEMORRHAGE 63 0.0037
432 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 28 0.0037
433 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 22 0.0037
434 PNEUMONIA BACTERIAL 34 0.0037
435 LEUKOPENIA 185 0.0037
436 ODYNOPHAGIA 22 0.0037
437 LIVER FUNCTION TEST INCREASED 79 0.0037
438 HYPERTONIA 21 0.0037
439 LOWER GASTROINTESTINAL HAEMORRHAGE 27 0.0036
440 HEPATITIS CHOLESTATIC 22 0.0036
441 FAECALOMA 20 0.0036
442 ALANINE AMINOTRANSFERASE INCREASED 224 0.0036
443 INTERNATIONAL NORMALISED RATIO INCREASED 104 0.0036
444 NEPHROTIC SYNDROME 25 0.0036
445 METABOLIC DISORDER 21 0.0036
446 UNEVALUABLE EVENT 271 0.0036
447 TOXICITY TO VARIOUS AGENTS 603 0.0036
448 PULMONARY CONGESTION 47 0.0036
449 SUPRAVENTRICULAR TACHYCARDIA 34 0.0035
450 TASTE DISORDER 72 0.0035
451 MOUTH HAEMORRHAGE 26 0.0035
452 CARDIO-RESPIRATORY ARREST 148 0.0035
453 GRIP STRENGTH DECREASED 31 0.0035
454 COLITIS ULCERATIVE 157 0.0035
455 STEVENS-JOHNSON SYNDROME 78 0.0035
456 PURPURA 31 0.0035
457 DEHYDRATION 466 0.0035
458 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
459 FOETAL DEATH 18 0.0035
460 BASAL CELL CARCINOMA 54 0.0035
461 HYPERTENSION 732 0.0035
462 MITRAL VALVE INCOMPETENCE 39 0.0034
463 GAMMA-GLUTAMYLTRANSFERASE INCREASED 75 0.0034
464 ATRIAL FLUTTER 27 0.0034
465 COMA 161 0.0034
466 RESPIRATORY TRACT INFECTION 88 0.0034
467 CONSTIPATION 734 0.0034
468 IRON DEFICIENCY ANAEMIA 31 0.0034
469 WHEEZING 198 0.0033
470 OEDEMA PERIPHERAL 406 0.0033
471 CARDIAC VALVE DISEASE 19 0.0033
472 ARTERIOSCLEROSIS CORONARY ARTERY 22 0.0033
473 HAEMOGLOBIN ABNORMAL 21 0.0033
474 RHINITIS 26 0.0032
475 COVID-19 PNEUMONIA 38 0.0032
476 GENERAL PHYSICAL HEALTH DETERIORATION 372 0.0032
477 CARDIAC FAILURE 258 0.0032
478 OEDEMA 174 0.0032
479 ASPERGILLUS INFECTION 21 0.0032
480 INTENTIONAL OVERDOSE 205 0.0032
481 PERITONITIS 66 0.0032
482 ATRIAL FIBRILLATION 310 0.0032
483 ESCHERICHIA INFECTION 26 0.0032
484 INCREASED TENDENCY TO BRUISE 29 0.0031
485 LIPASE INCREASED 24 0.0031
486 BLOOD SODIUM DECREASED 59 0.0031
487 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 163 0.0031
488 SMALL INTESTINAL OBSTRUCTION 38 0.0031
489 PNEUMONIA 993 0.0031
490 ECCHYMOSIS 21 0.0031
491 SUBARACHNOID HAEMORRHAGE 31 0.0030
492 RESPIRATORY RATE INCREASED 27 0.0030
493 BURNING SENSATION 209 0.0030
494 BLOOD ALKALINE PHOSPHATASE INCREASED 74 0.0030
495 PLASMA CELL MYELOMA 116 0.0030
496 RESPIRATORY DISTRESS 82 0.0030
497 ABDOMINAL DISTENSION 310 0.0030
498 TRANSAMINASES INCREASED 66 0.0030
499 IMMUNOSUPPRESSION 26 0.0029
500 PULMONARY HAEMORRHAGE 23 0.0029
501 URINARY RETENTION 98 0.0029
502 HEPATIC FUNCTION ABNORMAL 109 0.0029
503 MYELOSUPPRESSION 105 0.0029
504 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 75 0.0029
505 URINARY TRACT INFECTION 497 0.0029
506 CORONARY ARTERY DISEASE 88 0.0029
507 TACHYCARDIA 258 0.0029
508 BODY HEIGHT DECREASED 31 0.0029
509 HYPOGAMMAGLOBULINAEMIA 19 0.0029
510 CARDIAC MURMUR 25 0.0029
511 MIOSIS 23 0.0029
512 PERICARDIAL EFFUSION 66 0.0029
513 PRODUCTIVE COUGH 136 0.0028
514 PYREXIA 985 0.0028
515 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 156 0.0028
516 STAPHYLOCOCCAL INFECTION 93 0.0028
517 HYPOGLYCAEMIA 136 0.0028
518 MOUTH ULCERATION 59 0.0028
519 VENTRICULAR EXTRASYSTOLES 29 0.0028
520 HYPOPHAGIA 71 0.0028
521 WHITE BLOOD CELL COUNT DECREASED 301 0.0028
522 LOWER RESPIRATORY TRACT INFECTION 126 0.0028
523 MYOCLONUS 33 0.0028
524 EJECTION FRACTION DECREASED 43 0.0028
525 GASTROINTESTINAL HAEMORRHAGE 230 0.0027
526 VIRAL INFECTION 91 0.0027
527 DYSPEPSIA 269 0.0027
528 HOSPICE CARE 27 0.0027
529 DIABETES MELLITUS 208 0.0027
530 MYDRIASIS 35 0.0027
531 CHOLELITHIASIS 89 0.0027
532 CARDIOMYOPATHY 40 0.0027
533 BLOOD IRON DECREASED 32 0.0027
534 LIVER INJURY 66 0.0027
535 HEPATIC ENCEPHALOPATHY 25 0.0027
536 ALTERED STATE OF CONSCIOUSNESS 58 0.0027
537 BLOOD PRESSURE DECREASED 177 0.0027
538 MYOPATHY 23 0.0027
539 THROMBOSIS 214 0.0027
540 SUBDURAL HAEMATOMA 38 0.0027
541 GENERAL PHYSICAL CONDITION ABNORMAL 18 0.0027
542 SPLENOMEGALY 31 0.0026
543 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
544 RESTLESS LEGS SYNDROME 48 0.0026
545 MELAENA 58 0.0026
546 NEUTROPENIA 356 0.0026
547 QUALITY OF LIFE DECREASED 35 0.0026
548 HAEMORRHAGE INTRACRANIAL 39 0.0026
549 SYNOVITIS 47 0.0026
550 DELIRIUM 90 0.0026
551 PULMONARY EMBOLISM 246 0.0026
552 DRUG-INDUCED LIVER INJURY 81 0.0026
553 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
554 EMOTIONAL DISTRESS 311 0.0026
555 CELLULITIS 129 0.0026
556 PULMONARY MASS 38 0.0025
557 SEROTONIN SYNDROME 49 0.0025
558 CANDIDA INFECTION 43 0.0025
559 ACUTE MYOCARDIAL INFARCTION 75 0.0025
560 MICTURITION URGENCY 29 0.0025
561 INTESTINAL PERFORATION 28 0.0025
562 UPPER RESPIRATORY TRACT INFECTION 115 0.0025
563 FULL BLOOD COUNT DECREASED 50 0.0025
564 CARDIAC DISORDER 232 0.0025
565 ABDOMINAL PAIN 576 0.0025
566 PNEUMONITIS 67 0.0025
567 APHTHOUS ULCER 19 0.0024
568 SKIN ULCER 63 0.0024
569 CARDIAC FAILURE CONGESTIVE 194 0.0024
570 FISTULA 27 0.0024
571 FLUID RETENTION 122 0.0024
572 HEPATOCELLULAR INJURY 34 0.0024
573 LIVE BIRTH 20 0.0024
574 DRUG INTERACTION 379 0.0024
575 GINGIVAL PAIN 19 0.0024
576 PLATELET COUNT INCREASED 31 0.0024
577 BLOOD PRESSURE FLUCTUATION 57 0.0024
578 STOMATITIS 144 0.0024
579 BLOOD URINE PRESENT 45 0.0024
580 BLOOD CHOLESTEROL INCREASED 110 0.0024
581 VITAMIN D DEFICIENCY 23 0.0024
582 FOOT DEFORMITY 26 0.0023
583 CONFUSIONAL STATE 376 0.0023
584 GASTRITIS 61 0.0023
585 DECREASED ACTIVITY 25 0.0023
586 LACRIMATION INCREASED 70 0.0023
587 HAEMATOMA 60 0.0023
588 OSTEOPENIA 35 0.0023
589 LABORATORY TEST ABNORMAL 68 0.0023
590 LIVER DISORDER 102 0.0023
591 PETECHIAE 24 0.0023
592 ACUTE CORONARY SYNDROME 19 0.0023
593 WEIGHT FLUCTUATION 24 0.0023
594 DIARRHOEA 1477 0.0023
595 PNEUMOTHORAX 36 0.0023
596 CHOLECYSTITIS 27 0.0023
597 OSTEOMYELITIS 41 0.0023
598 BLOOD CREATINE PHOSPHOKINASE INCREASED 65 0.0023
599 ASTHMA 255 0.0023
600 WEIGHT DECREASED 629 0.0023
601 CHOLESTASIS 43 0.0022
602 ARRHYTHMIA 105 0.0022
603 SPUTUM DISCOLOURED 21 0.0022
604 BLOOD PRESSURE ABNORMAL 44 0.0022
605 HAEMATEMESIS 56 0.0022
606 BLOOD PRESSURE SYSTOLIC INCREASED 43 0.0022
607 LIVER FUNCTION TEST ABNORMAL 64 0.0022
608 DYSURIA 81 0.0022
609 ACUTE HEPATIC FAILURE 30 0.0022
610 FOLLICULITIS 23 0.0022
611 HICCUPS 18 0.0022
612 SKIN LESION 60 0.0022
613 DYSPNOEA EXERTIONAL 82 0.0022
614 NAIL DISORDER 19 0.0022
615 SWELLING 203 0.0022
616 GRAND MAL CONVULSION 20 0.0022
617 SCAR 37 0.0022
618 HAEMOPTYSIS 60 0.0021
619 SEIZURE 247 0.0021
620 PALLOR 58 0.0021
621 DECREASED APPETITE 495 0.0021
622 DRUG TOXICITY 29 0.0021
623 INTERSTITIAL LUNG DISEASE 103 0.0021
624 HAEMORRHAGE 222 0.0021
625 GASTROINTESTINAL INFECTION 19 0.0021
626 APHASIA 64 0.0021
627 GLYCOSYLATED HAEMOGLOBIN INCREASED 53 0.0021
628 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
629 NEPHROLITHIASIS 96 0.0021
630 IMMUNODEFICIENCY 31 0.0021
631 RED BLOOD CELL SEDIMENTATION RATE INCREASED 23 0.0021
632 TRANSIENT ISCHAEMIC ATTACK 70 0.0021
633 EPISTAXIS 155 0.0021
634 SLEEP DISORDER 146 0.0021
635 LOCALISED INFECTION 50 0.0021
636 OSTEOPOROSIS 85 0.0021
637 HEPATOTOXICITY 46 0.0021
638 ADRENAL INSUFFICIENCY 25 0.0021
639 PRODUCT PRESCRIBING ERROR 49 0.0021
640 HOSPITALISATION 316 0.0021
641 ACUTE MYELOID LEUKAEMIA 32 0.0021
642 CEREBRAL INFARCTION 50 0.0020
643 VOMITING 960 0.0020
644 KIDNEY INFECTION 40 0.0020
645 INTESTINAL OBSTRUCTION 76 0.0020
646 TENDERNESS 21 0.0020
647 HAEMOLYTIC ANAEMIA 18 0.0020
648 SCIATICA 32 0.0020
649 DEEP VEIN THROMBOSIS 129 0.0020
650 OXYGEN SATURATION DECREASED 111 0.0020
651 JAUNDICE 53 0.0020
652 PERICARDITIS 33 0.0020
653 BODY TEMPERATURE INCREASED 40 0.0020
654 PANCREATITIS ACUTE 44 0.0020
655 CYSTITIS 62 0.0019
656 OFF LABEL USE 1699 0.0019
657 INFUSION SITE PAIN 25 0.0019
658 PULMONARY FIBROSIS 37 0.0019
659 BLOOD PRESSURE INCREASED 294 0.0019
660 DRY MOUTH 156 0.0019
661 DEVICE OCCLUSION 27 0.0019
662 ASTHENIA 716 0.0019
663 TREATMENT NONCOMPLIANCE 104 0.0019
664 INTENTIONAL PRODUCT MISUSE 166 0.0019
665 PANCREATITIS 100 0.0019
666 RASH MACULO-PAPULAR 42 0.0019
667 PREMATURE DELIVERY 30 0.0019
668 PRODUCT ADMINISTRATION ERROR 38 0.0019
669 HEART RATE DECREASED 66 0.0019
670 JOINT STIFFNESS 49 0.0019
671 LUNG INFECTION 29 0.0019
672 DYSPNOEA 1054 0.0019
673 ABDOMINAL PAIN LOWER 47 0.0019
674 IMPAIRED HEALING 61 0.0019
675 HIATUS HERNIA 24 0.0019
676 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 43 0.0018
677 HEMIPARESIS 31 0.0018
678 CONDITION AGGRAVATED 556 0.0018
679 EYE DISCHARGE 19 0.0018
680 JOINT INJURY 39 0.0018
681 THERAPY NON-RESPONDER 82 0.0018
682 CORONARY ARTERY OCCLUSION 25 0.0018
683 NOCTURIA 22 0.0018
684 RIB FRACTURE 37 0.0018
685 LUNG DISORDER 88 0.0018
686 RENAL PAIN 19 0.0018
687 SWELLING FACE 116 0.0018
688 FLATULENCE 101 0.0018
689 LIMB INJURY 48 0.0018
690 WOUND 49 0.0018
691 TYPE 2 DIABETES MELLITUS 58 0.0017
692 ACCIDENTAL OVERDOSE 63 0.0017
693 POST PROCEDURAL COMPLICATION 33 0.0017
694 GASTROENTERITIS VIRAL 31 0.0017
695 SICKLE CELL ANAEMIA WITH CRISIS 27 0.0017
696 FAECES DISCOLOURED 37 0.0017
697 CEREBRAL HAEMORRHAGE 61 0.0017
698 HEPATIC ENZYME INCREASED 116 0.0017
699 EPILEPSY 52 0.0017
700 ABSCESS 27 0.0017
701 GINGIVAL BLEEDING 23 0.0017
702 THIRST 30 0.0017
703 SKIN DISORDER 56 0.0017
704 INFECTION 243 0.0017
705 HAND DEFORMITY 22 0.0017
706 CONTUSION 161 0.0017
707 SYNCOPE 167 0.0017
708 LETHARGY 96 0.0017
709 DIABETIC KETOACIDOSIS 40 0.0017
710 MYELODYSPLASTIC SYNDROME 24 0.0017
711 VERTIGO 101 0.0017
712 CYANOSIS 26 0.0017
713 HEPATIC CIRRHOSIS 31 0.0016
714 HEAD INJURY 52 0.0016
715 HEPATITIS 42 0.0016
716 MUSCLE SPASTICITY 20 0.0016
717 SEASONAL ALLERGY 23 0.0016
718 PAIN 996 0.0016
719 INTENTIONAL PRODUCT USE ISSUE 142 0.0016
720 ANXIETY 461 0.0016
721 PERIPHERAL SWELLING 246 0.0016
722 DERMATITIS ALLERGIC 20 0.0016
723 MUSCLE RIGIDITY 19 0.0016
724 DIVERTICULITIS 44 0.0016
725 DIABETES MELLITUS INADEQUATE CONTROL 28 0.0016
726 SYSTEMIC LUPUS ERYTHEMATOSUS 56 0.0016
727 SWOLLEN TONGUE 49 0.0016
728 SINUS DISORDER 31 0.0016
729 BONE DENSITY DECREASED 49 0.0016
730 AGEUSIA 39 0.0016
731 RESTLESSNESS 57 0.0016
732 URINARY INCONTINENCE 46 0.0016
733 DYSSTASIA 45 0.0015
734 EOSINOPHILIA 27 0.0015
735 IMPAIRED GASTRIC EMPTYING 21 0.0015
736 DISEASE PROGRESSION 181 0.0015
737 NAUSEA 1209 0.0015
738 BRONCHITIS 113 0.0015
739 BEDRIDDEN 20 0.0015
740 CONTRAINDICATED PRODUCT ADMINISTERED 46 0.0015
741 INCREASED APPETITE 29 0.0015
742 HALLUCINATION, VISUAL 32 0.0015
743 ADVERSE REACTION 20 0.0015
744 INSURANCE ISSUE 23 0.0015
745 FUNGAL INFECTION 50 0.0015
746 HERPES ZOSTER 86 0.0015
747 DRUG INTOLERANCE 144 0.0015
748 LYMPHOMA 23 0.0015
749 OSTEOARTHRITIS 63 0.0015
750 DRUG RESISTANCE 38 0.0015
751 LOSS OF CONSCIOUSNESS 189 0.0015
752 GASTRIC ULCER 28 0.0015
753 PRODUCT USE IN UNAPPROVED INDICATION 365 0.0015
754 AGITATION 108 0.0015
755 MATERNAL EXPOSURE DURING PREGNANCY 131 0.0015
756 ANGINA PECTORIS 42 0.0015
757 MOVEMENT DISORDER 47 0.0015
758 HIP FRACTURE 47 0.0015
759 CARDIOVASCULAR DISORDER 37 0.0015
760 FALL 481 0.0014
761 CHILLS 169 0.0014
762 LYMPHADENOPATHY 51 0.0014
763 GLOSSODYNIA 32 0.0014
764 SYRINGE ISSUE 25 0.0014
765 NIGHT SWEATS 46 0.0014
766 FOOT FRACTURE 27 0.0014
767 MEDICATION ERROR 79 0.0014
768 MALAISE 623 0.0014
769 ERYTHEMA 291 0.0014
770 POLLAKIURIA 59 0.0014
771 DRUG ERUPTION 25 0.0014
772 GASTROINTESTINAL DISORDER 126 0.0014
773 ISCHAEMIC STROKE 25 0.0014
774 OVERDOSE 302 0.0014
775 NEUROPATHY PERIPHERAL 133 0.0014
776 PARALYSIS 20 0.0014
777 COVID-19 244 0.0014
778 INFLUENZA 155 0.0014
779 ORAL PAIN 31 0.0014
780 EXPOSURE DURING PREGNANCY 86 0.0014
781 CHEST PAIN 256 0.0014
782 DYSARTHRIA 52 0.0014
783 RESPIRATORY ARREST 38 0.0014
784 COMPLICATION ASSOCIATED WITH DEVICE 20 0.0014
785 PRODUCT PRESCRIBING ISSUE 30 0.0014
786 GAIT INABILITY 46 0.0014
787 CEREBROVASCULAR ACCIDENT 233 0.0014
788 HEADACHE 860 0.0014
789 RESPIRATORY DISORDER 41 0.0014
790 MUSCULOSKELETAL STIFFNESS 120 0.0014
791 PREMATURE BABY 41 0.0014
792 PRODUCT USE ISSUE 255 0.0014
793 DEPRESSION 306 0.0013
794 RASH PAPULAR 30 0.0013
795 PHOTOPHOBIA 25 0.0013
796 TOOTHACHE 24 0.0013
797 TREMOR 220 0.0013
798 HEART RATE INCREASED 131 0.0013
799 BLISTER 74 0.0013
800 NERVOUS SYSTEM DISORDER 41 0.0013
801 RETCHING 28 0.0013
802 HYPOKINESIA 19 0.0013
803 MYOCARDIAL INFARCTION 225 0.0013
804 MUSCULAR WEAKNESS 146 0.0013
805 DYSPHONIA 75 0.0013
806 PSORIATIC ARTHROPATHY 52 0.0013
807 BACK PAIN 297 0.0013
808 MULTIPLE FRACTURES 21 0.0013
809 COLON CANCER 19 0.0013
810 RASH PRURITIC 69 0.0013
811 SOMNOLENCE 256 0.0013
812 DISORIENTATION 50 0.0013
813 DRUG INEFFECTIVE 1662 0.0013
814 PRESCRIBED UNDERDOSE 25 0.0013
815 IMPAIRED QUALITY OF LIFE 18 0.0013
816 DEATH 1076 0.0012
817 FATIGUE 971 0.0012
818 CHROMATURIA 28 0.0012
819 EAR INFECTION 33 0.0012
820 COUGH 347 0.0012
821 ABDOMINAL DISCOMFORT 206 0.0012
822 FEELING COLD 34 0.0012
823 HYPERSOMNIA 35 0.0012
824 CHEST DISCOMFORT 124 0.0012
825 BLOOD GLUCOSE INCREASED 228 0.0012
826 THERAPEUTIC PRODUCT EFFECT DECREASED 54 0.0012
827 ARTHRITIS 94 0.0012
828 ABDOMINAL PAIN UPPER 245 0.0012
829 BLOOD COUNT ABNORMAL 18 0.0012
830 FEEDING DISORDER 24 0.0012
831 MOBILITY DECREASED 85 0.0012
832 INFLAMMATION 61 0.0012
833 DEMENTIA 33 0.0012
834 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 84 0.0012
835 DRUG DISPENSING ERROR 18 0.0012
836 MUSCLE SPASMS 216 0.0012
837 MUSCLE TWITCHING 27 0.0012
838 DYSGEUSIA 87 0.0012
839 TINNITUS 53 0.0012
840 SKIN DISCOLOURATION 53 0.0012
841 BONE DISORDER 21 0.0012
842 BLOOD GLUCOSE DECREASED 55 0.0011
843 NECK PAIN 64 0.0011
844 GAIT DISTURBANCE 219 0.0011
845 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
846 ADVERSE EVENT 105 0.0011
847 CONVULSION 65 0.0011
848 ABASIA 28 0.0011
849 CONJUNCTIVITIS 21 0.0011
850 DYSKINESIA 46 0.0011
851 FACE OEDEMA 19 0.0011
852 NASOPHARYNGITIS 207 0.0011
853 SUICIDE ATTEMPT 68 0.0011
854 DISABILITY 22 0.0011
855 CATARACT 66 0.0011
856 ILL-DEFINED DISORDER 67 0.0011
857 FEMUR FRACTURE 34 0.0011
858 HYPOAESTHESIA 164 0.0011
859 EATING DISORDER 23 0.0011
860 HYPERHIDROSIS 139 0.0011
861 IMPAIRED WORK ABILITY 23 0.0011
862 MEMORY IMPAIRMENT 147 0.0011
863 DIZZINESS 532 0.0011
864 DISCOMFORT 65 0.0011
865 GALLBLADDER DISORDER 19 0.0011
866 DYSPHAGIA 101 0.0011
867 PAIN IN EXTREMITY 312 0.0011
868 MYALGIA 179 0.0011
869 MUSCULOSKELETAL PAIN 55 0.0010
870 OROPHARYNGEAL PAIN 96 0.0010
871 TOOTH DISORDER 23 0.0010
872 PRESCRIBED OVERDOSE 20 0.0010
873 FOETAL EXPOSURE DURING PREGNANCY 84 0.0010
874 ANAPHYLACTIC REACTION 57 0.0010
875 HEAD DISCOMFORT 18 0.0010
876 RASH GENERALISED 26 0.0010
877 THROAT TIGHTNESS 27 0.0010
878 MENTAL IMPAIRMENT 24 0.0010
879 PAIN IN JAW 28 0.0010
880 MALIGNANT NEOPLASM PROGRESSION 101 0.0010
881 PRODUCT DOSE OMISSION 64 0.0010
882 POOR QUALITY SLEEP 21 0.0010
883 PRODUCT PREPARATION ERROR 20 0.0010
884 TOOTH LOSS 20 0.0010
885 DRUG DOSE OMISSION 159 0.0010
886 PARAESTHESIA 151 0.0010
887 WEIGHT INCREASED 214 0.0010
888 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 172 0.0010
889 UPPER LIMB FRACTURE 19 0.0010
890 NASAL CONGESTION 56 0.0010
891 INSOMNIA 253 0.0009
892 GLAUCOMA 18 0.0009
893 ANAPHYLACTIC SHOCK 24 0.0009
894 HALLUCINATION 70 0.0009
895 BALANCE DISORDER 80 0.0009
896 ILLNESS 95 0.0009
897 EYE PAIN 52 0.0009
898 RASH ERYTHEMATOUS 44 0.0009
899 EMOTIONAL DISORDER 28 0.0009
900 PRODUCT DOSE OMISSION ISSUE 267 0.0009
901 SINUSITIS 93 0.0009
902 DERMATITIS 19 0.0009
903 HYPOACUSIS 39 0.0009
904 PRURITUS 348 0.0009
905 ANGIOEDEMA 40 0.0009
906 THERAPEUTIC RESPONSE DECREASED 54 0.0009
907 JOINT SWELLING 107 0.0009
908 HEART RATE IRREGULAR 20 0.0009
909 RHINORRHOEA 57 0.0009
910 DRUG ADMINISTRATION ERROR 27 0.0009
911 THERAPY CESSATION 45 0.0009
912 ABORTION SPONTANEOUS 34 0.0008
913 FEELING HOT 52 0.0008
914 RASH 368 0.0008
915 INTENTIONAL DOSE OMISSION 24 0.0008
916 BONE PAIN 49 0.0008
917 SURGERY 49 0.0008
918 RASH MACULAR 29 0.0008
919 DRUG ABUSE 69 0.0008
920 PALPITATIONS 97 0.0008
921 PANIC ATTACK 30 0.0008
922 DISEASE RECURRENCE 39 0.0008
923 LIP SWELLING 27 0.0008
924 PROSTATE CANCER 65 0.0008
925 ECZEMA 41 0.0008
926 HYPERSENSITIVITY 144 0.0008
927 ARTHRALGIA 318 0.0008
928 THERAPY INTERRUPTED 53 0.0007
929 MENTAL DISORDER 32 0.0007
930 OSTEONECROSIS 24 0.0007
931 NERVOUSNESS 38 0.0007
932 SKIN EXFOLIATION 61 0.0007
933 ARTHROPATHY 40 0.0007
934 LIMB DISCOMFORT 22 0.0007
935 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
936 DEPRESSED MOOD 37 0.0007
937 MOOD ALTERED 19 0.0007
938 VISUAL ACUITY REDUCED 23 0.0007
939 MIGRAINE 66 0.0007
940 VISUAL IMPAIRMENT 85 0.0007
941 VISION BLURRED 94 0.0007
942 EYE PRURITUS 23 0.0007
943 OCULAR HYPERAEMIA 32 0.0007
944 SPEECH DISORDER 35 0.0007
945 COGNITIVE DISORDER 31 0.0007
946 NEOPLASM PROGRESSION 23 0.0007
947 HOT FLUSH 49 0.0006
948 DEVICE LEAKAGE 28 0.0006
949 GASTRIC DISORDER 22 0.0006
950 TREATMENT FAILURE 53 0.0006
951 FLUSHING 65 0.0006
952 NIGHTMARE 22 0.0006
953 FEELING ABNORMAL 151 0.0006
954 EYE IRRITATION 36 0.0006
955 DRY SKIN 83 0.0006
956 DRY EYE 31 0.0006
957 EYE DISORDER 20 0.0006
958 IRRITABILITY 36 0.0006
959 EYE SWELLING 22 0.0006
960 BLINDNESS 24 0.0006
961 COMPLETED SUICIDE 49 0.0006
962 URTICARIA 96 0.0006
963 UNDERDOSE 41 0.0006
964 LUNG NEOPLASM MALIGNANT 23 0.0006
965 THROAT IRRITATION 25 0.0006
966 ADVERSE DRUG REACTION 50 0.0006
967 INCORRECT DOSE ADMINISTERED 127 0.0006
968 AMNESIA 35 0.0005
969 DRUG EFFECT INCOMPLETE 19 0.0005
970 AGGRESSION 26 0.0005
971 DEVICE BREAKAGE 21 0.0005
972 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
973 ABNORMAL BEHAVIOUR 20 0.0005
974 NO ADVERSE EVENT 91 0.0005
975 ALOPECIA 96 0.0005
976 PRODUCT QUALITY ISSUE 66 0.0005
977 DEVICE DISLOCATION 21 0.0005
978 DEVICE ISSUE 43 0.0005
979 DISTURBANCE IN ATTENTION 25 0.0005
980 VAGINAL HAEMORRHAGE 20 0.0005
981 INFLUENZA LIKE ILLNESS 34 0.0004
982 INJECTION SITE ERYTHEMA 51 0.0004
983 DRUG EFFECT DECREASED 22 0.0004
984 INJECTION SITE PAIN 121 0.0004
985 NEOPLASM MALIGNANT 26 0.0004
986 RHEUMATOID ARTHRITIS 44 0.0004
987 INJECTION SITE HAEMORRHAGE 30 0.0004
988 PSORIASIS 48 0.0004
989 INJECTION SITE REACTION 25 0.0004
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 71 0.0004
991 DEVICE MALFUNCTION 24 0.0003
992 ACNE 25 0.0003
993 INJECTION SITE SWELLING 24 0.0003
994 INJECTION SITE BRUISING 22 0.0003
995 DRUG DEPENDENCE 26 0.0002